Data for: Antidepressants and suicidality: A re-analysis of the re-analysis.

Published: 29 Feb 2020 | Version 2 | DOI: 10.17632/nt272t2bxc.2
Contributor(s):

Description of this data

Data on number of suicide and suicide attempts from the Integrated Safety Summaries included in the New Drug Approval registration packets for 14 antidepressants approved between 1991 and 2013 as reported by

Khan A, Fahl Mar K, Gokul S, Brown WA. Decreased suicide rates in recent antidepressant clinical trials. Psychopharmacology (Berl). 2018;235(5):1455–62.

and

Hengartner MP, Plöderl M. Newer-Generation Antidepressants and Suicide Risk in Randomized Controlled Trials: A Re-Analysis of the FDA Database. Psychother Psychosom [Internet]. 2019;1–2. Available from: https://www.karger.com/Article/FullText/501215

Experiment data files

Latest version

  • Version 2

    2020-02-29

    Published: 2020-02-29

    DOI: 10.17632/nt272t2bxc.2

    Cite this dataset

    Kaminski, Jakob; Bschor, Tom (2020), “Data for: Antidepressants and suicidality: A re-analysis of the re-analysis.”, Mendeley Data, v2 http://dx.doi.org/10.17632/nt272t2bxc.2

Statistics

Views: 74
Downloads: 179

Previous versions

Compare to version

Categories

Psychiatry, Adverse Event

Licence

CC BY 4.0 Learn more

The files associated with this dataset are licensed under a Creative Commons Attribution 4.0 International licence.

What does this mean?
You can share, copy and modify this dataset so long as you give appropriate credit, provide a link to the CC BY license, and indicate if changes were made, but you may not do so in a way that suggests the rights holder has endorsed you or your use of the dataset. Note that further permission may be required for any content within the dataset that is identified as belonging to a third party.

Report